Mapping the EORTC QLQ-C30 to EQ-5D-3L in patients with breast cancer

BACKGROUND: The types of outcomes measured collected in clinical studies and those required for cost-effectiveness analysis often differ. Decision makers routinely use quality adjusted life years (QALYs) to compare the benefits and costs of treatments across different diseases and treatments using a...

Descripción completa

Detalles Bibliográficos
Autores principales: Gray, Laura A., Hernandez Alava, Monica, Wailoo, Allan J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8600775/
https://www.ncbi.nlm.nih.gov/pubmed/34794404
http://dx.doi.org/10.1186/s12885-021-08964-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8600775/
https://www.ncbi.nlm.nih.gov/pubmed/34794404
http://dx.doi.org/10.1186/s12885-021-08964-5

Ejemplares similares